Avid Logo June 2022.jpg
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
30 nov. 2023 16h05 HE | Avid Bioservices, Inc
TUSTIN, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – BCLI
26 nov. 2023 21h36 HE | The Rosen Law Firm PA
NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI)...
Avid Logo June 2022.jpg
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
08 nov. 2023 08h05 HE | Avid Bioservices, Inc
TUSTIN, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
AMR Logo.png
Asia-Pacific Anti-inflammatory Therapeutics Market to Reach $40.5 Billion by 2032 With CAGR of 5.4%: Says Allied Market Research  
05 nov. 2023 18h55 HE | Allied Market Research
Wilmington, Delaware, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Asia-Pacific Anti-inflammatory Therapeutics Market, By Drug Class (Biologics, NSAIDs,...
Avid Logo June 2022.jpg
Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility
17 oct. 2023 08h05 HE | Avid Bioservices, Inc
Avid completes construction of cell and gene theapy facility bringing total revenue generating capacity to up to ~$400 Million annually
Transparency Market Research
Atopic Dermatitis Drugs Market Size to Surpass USD 28.2 billion by 2031, at a CAGR of 8.9% | Transparency Market Research Inc.
16 oct. 2023 12h30 HE | Transparency Market Research
Wilmington, Delaware, United States, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global atopic dermatitis drugs market is likely to develop at an 8.9% CAGR from 2023 to...
TIP_link_300x300.jpg
Pharmaceutical Contract Sales Organizations Market Worth $15.82 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
16 oct. 2023 08h31 HE | The Insight Partners
Pune, India, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Pharmaceutical companies may outsource their sales and marketing functions to third parties, commonly referred to as contract sales organizations,...
Dyadic Logo Current.jpg
Dyadic Appoints Doug Pace to Its Executive Leadership Team
09 oct. 2023 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Avid Logo June 2022.jpg
Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference
26 sept. 2023 16h05 HE | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Straits Research Pvt Ltd
Regenerative Medicine Market Size is projected to reach USD 72.2 Billion by 2030, growing at a CAGR of 17.6%: Straits Research
18 sept. 2023 11h20 HE | Straits Research
New York, United States, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Regenerative drugs are used to repair, swap out, and regenerate tissues and organs harmed by injury, disease, or normal aging. Cell...